Dashboard: VC-backed M&A heats up in December; IPOs remain cold

M&A proceeds spiked in December thanks to Bristol-Myers' $2.1 billion acquisition of Cardioxyl, the largest acquisition of a venture-backed company in 2015

DealsFeaturedManagersResearchFeatured